Wed, November 16, 2022

Salim Syed Maintained (ASMB) at Strong Buy with Decreased Target to $36 on, Nov 16th, 2022

-
Salim Syed of Mizuho, Maintained "Assembly Biosciences, Inc." (ASMB) at Strong Buy with Decreased Target from $168 to $36 on, Nov 16th, 2022.

Salim has made no other calls on ASMB in the last 4 months.



There is 1 other peer that has a rating on ASMB. Out of the 1 peers that are also analyzing ASMB, all agrees with Salim's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Nicole Germino of "Truist Securities" Downgraded from Strong Buy to Hold and Decreased Target to $24 on, Monday, October 24th, 2022
-